These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases. Schiavotto C; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754 [TBL] [Abstract][Full Text] [Related]
6. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
7. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases. Li HQ; Zhang L; Zhao H; Ji LX; Yang RC Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223 [TBL] [Abstract][Full Text] [Related]
8. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura. Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739 [TBL] [Abstract][Full Text] [Related]
9. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Aleem A Platelets; 2011; 22(1):1-7. PubMed ID: 20964585 [TBL] [Abstract][Full Text] [Related]
10. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Kumar S; Diehn FE; Gertz MA; Tefferi A Ann Hematol; 2002 Jun; 81(6):312-9. PubMed ID: 12107560 [TBL] [Abstract][Full Text] [Related]
11. Role of splenectomy in chronic idiopathic thrombocytopenic purpura. Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258 [TBL] [Abstract][Full Text] [Related]
12. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360 [TBL] [Abstract][Full Text] [Related]
17. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura. Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic splenectomy and the treatment outcomes for idiopathic thrombocytopaenic purpura at North Shore Hospital. Prasad S; Harman R; Henderson R; Chunnilal S; Simpson D N Z Med J; 2009 Jun; 122(1297):38-48. PubMed ID: 19649000 [TBL] [Abstract][Full Text] [Related]
19. [Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura]. Kiudelis M; Endzinas Z; Mickevicius A; Reckauskas M Zentralbl Chir; 2004 Apr; 129(2):108-13. PubMed ID: 15106041 [TBL] [Abstract][Full Text] [Related]
20. Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura. Donato H; Picón A; Rapetti MC; Rosso A; Schvartzman G; Drozdowski C; Di Santo JJ Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):737-9. PubMed ID: 16933257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]